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Knee Enthesitis and Synovitis on Magnetic Resonance
Imaging in Patients with Psoriasis without Arthritic
Symptoms 
YASSER EMAD, YASSER RAGAB, TAMER GHEITA, ASHRAF ANBAR, HODA KAMAL, AHMED SAAD, 
HANAN DARWEESH, NASHWA EL-SHAARAWY, AMR AZAB, AHMED ISMAIL, and JOHANNES J. RASKER; 
Knee Enthesitis Working Group
ABSTRACT. Objective. This case-control study was designed to evaluate magnetic resonance imaging (MRI)
findings of knee joints in patients with psoriasis without clinical peripheral or axial joint involve-
ment, and to correlate MRI findings with disease and demographic variables.
Methods. In total 48 patients with  psoriasis and no clinical evidence of synovitis or enthesitis in any
peripheral or axial joints were enrolled. A random sample of 20 healthy subjects without knee or
other joint complaints and matched for age and sex served as controls. All patients and controls
underwent enhanced MRI studies of both knee joints, and MRI findings were compared.
Results.Among 48 patients (96 knees), a total of 90 entheseal lesions were detected, with no enthe-
sitis in 2 cases (6.3%). Signs of continuing inflammation bilaterally were frequently found: soft tis-
sue edema (STE; n = 52), bone marrow edema (BME; n = 20), perientheseal BME (n = 3), carti-
laginous erosions (n = 42), and bone erosions (n = 27). In controls, 2 (10%) subjects had BME and
another 5 (25%) showed cartilaginous erosions. None showed evidence of enthesitis. Significant
correlations were observed between the number of entheseal lesions of both knees vs STE (present
vs absent; r = 0.314, p = 0.030) and STE (number of lesions; r = 0.351, p = 0.014). Enthesitis (uni-
lateral vs bilateral) was significantly and positively correlated with STE (r = 0.304, p = 0.036), car-
tilaginous erosions (r = 0.304, p = 0.036), and villous projections (r = 0.347, p = 0.016).
Conclusion. Subclinical synovitis and enthesitis are frequently found in the knee joint of patients
with  psoriasis. These may be an early sign of psoriatic arthritis. (First Release Aug 1 2012; 
J Rheumatol 2012;39:1979–86; doi:10.3899/jrheum.120301)
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“Enthesitis,” the term used to describe inflammation at ten-
don, ligament, or joint capsule insertions, is included in the
European Spondylarthropathy Study Group criteria for the
classification of spondyloarthropathy (SpA). Evaluation of
entheseal-related changes at different joints by magnetic
resonance imaging (MRI) became an important topic on the
research agenda in both differentiated and undifferentiated
arthritis. If enthesitis is the primary event and synovitis fol-
lows, the presence of enthesitis among patients with  psori-
asis with no evidence of clinical arthritis could be a predic-
tor of psoriatic arthritis (PsA)1.
The advent of MRI and better understanding of joint
microanatomy including the complexity of joint entheses
provide a unifying anatomical and biomechanical concept
that links disease at the apparently disparate sites of
involvement in PsA, including the synovium, enthesis,
bone, and periosteum. These findings suggest an explana-
tion for the localization of disease to skeletal sites that are
subject to repeated mechanical stress2. There appear to be 2
patterns of inflammation: the “rheumatoid arthritis” (RA)
phenotype, where synovial involvement is the primary tar-
get of inflammation, and the “SpA” pattern, where enthesi-
tis comes first, followed by synovitis1,3,4,5.
Regarding enthesitis of the knee joint in SpA,
McGonagle and colleagues3 were the first to describe char-
acteristic MRI entheseal changes involving the knee joints
in a cohort of 10 patients with SpA (3 of whom had PsA)
with knee swelling of recent onset. This finding was con-
firmed by our group5. We compared enhanced MRI findings
of the knee joints in 3 groups of patients, undifferentiated
arthritis (UA; n = 25), established RA (n = 15), and SpA (n
= 15), and found that enthesitis was a common feature on
MRI in the SpA group, was totally absent in the group of
patients with RA, and was observed in 3 patients in the UA
group. We recommended that enthesitis as found on MRI
could help to classify patients presenting with UA of the
knee joint. Our group4 investigated enthesitis and enthe-
seal-related changes shown on knee MRI among patients
with several SpA. We found enthesitis in the knees of 56
patients including 30 with PsA, 5 with ankylosing spondyli-
tis, 5 with reactive arthritis, 5 with ulcerative colitis, and 5
with Crohn’s disease. A provocative finding was the pres-
ence of enthesitis of the knee joint among 6 patients with
psoriasis without clinical synovitis, who were not receiving
any disease-modifying antirheumatic drugs (DMARD). In
the psoriasis group (n = 6), 1 had bone marrow edema
(BME),  and enthesitis was detected in 5 patients at the
patellar tendon insertion (PTI) and in 1 case in the medial
patellofemoral ligament (MPFL)4.
These preliminary findings led us to look for enthesitis
and entheseal-related changes in the knees among patients
with only psoriasis without clinical evidence of peripheral
or axial joint involvement, and to analyze a possible relation
between enthesitis and other variables (such as demograph-
ic data, disease characteristics, severity and extension of
psoriatic lesions) with other MRI signs suggestive of con-
tinuing inflammation in the knee joints [such as soft tissue
edema (STE), BME, perientheseal BME, and cartilaginous
and bone erosions].
MATERIALS AND METHODS
Study population. Consecutive outpatients with psoriasis were included
with no clinical evidence of synovitis or enthesitis at clinical examination.
A convenience sample of 20 healthy subjects with no knee complaints
served as a control group.
Clinical evaluation and assessment. At baseline, a full history was taken
and a complete clinical examination was performed. Detailed rheumato-
logical examinations included peripheral and axial joint assessment
(sacroiliac joints, axial mobility tests, and chest expansion), evaluation of
extraarticular features such as nail lesions (pits and onycholysis), dactylitis,
enthesitis, distal interphalangeal joint involvement, and tenosynovitis.
Skin assessment. The Psoriasis Area and Severity Index (PASI) is used to
express the severity of psoriasis6. It combines the severity (erythema,
induration, and desquamation) and percentage of the affected area into a
single score in the range 0 (no disease) to 72 (maximal disease) as follows. 
Severity.A representative area of psoriasis is selected for each body region.
The intensity of redness, thickness, and scaling of the psoriasis is assessed
as none (0), mild (1), moderate (2), severe (3), or very severe (4). 
Area. The percentage area affected by psoriasis is evaluated in the 4 regions
of the body (head and neck, upper limbs, trunk, lower limbs). In each
region, the area is expressed as nil (0), 1%−9% (1), 13%−29% (2),
30%−49% (3), 50%−69% (4), 70%−89% (5), or 90%−100% (6)6.
MRI protocol and data acquisition. MRI/gadolinium-enhanced MRI was
undertaken for both knees in all patients. Results are given as per-patient,
to increase sensitivity. A General Electric echo speed 1.5-Tesla MR unit
equipped with a dedicated cylindrical knee coil was used. Sagittal, coronal,
and axial T1-weighted spin-echo MR images were obtained with the fol-
lowing MRI sequences: coronal T2-weighted TR: repetition time
(TR)/echo time (TE) 2600−24/68, matrix size 256 × 160, section thickness
4 mm, spacing 0.5 mm, field of view (FOV) 16 × 16; coronal short-tau
inversion recovery sequence (STIR) TR/TE 5250−94/68, matrix size 256 ×
160, section thickness 4 mm, spacing 0.5 mm, FOV 16 × 16; sagittal T2
TR/TE 2600−24/68, matrix size 256 × 160, section thickness 4 mm, spac-
ing 0.5 mm, FOV 16 × 16; sagittal STIR TR/TE 5250-49, matrix size 256
× 160, section thickness 4 mm, spacing 0.5 mm, FOV 16 × 16; axial T1
TR/TE 450−11.2, matrix size 320 × 192, section thickness 4 mm, spacing
0.5 mm, FOV 16 × 16; and axial T2 TR/TE 2600−23.5, matrix size 256 ×
192, section thickness 4 mm, spacing 0.5 mm, FOV 16 × 16. Immediately
after the acquisition of baseline images, an 0.05 mmol/kg body weight
intravenous bolus of Gd-DTPA (Schering, Berlin, Germany) was given,
including fat saturation.
Interpretation of MRI findings. MR images were evaluated for the follow-
ing radiological signs before and after intravenous contrast injection: BME,
perientheseal BME, bone erosions, cartilaginous erosions, synovial
enhancement and degree of synovial thickness, Baker’s cyst, periarticular
soft-tissue edema, and knee effusion.
Articular cartilage was assessed for contour (smooth vs irregular) and
focal destruction (intact, superficial loss and/or thinning, or deep erosions
to subchondral bone). Bone was assessed for marrow signal intensity
abnormalities and focal erosions. Maximal synovium thickness was meas-
ured in the suprapatellar pouch on sagittal T1-weighted Gd-enhanced
images, as in our earlier studies4,5. Special emphasis was given to the fol-
lowing entheseal sites and they were carefully evaluated for abnormalities:
the quadriceps tendon insertion and the proximal and distal patellar tendon.
The iliotibial band insertion, the medial collateral ligament (MCL) origin
and insertion, the lateral collateral ligament (LCL) origin and insertion, the
lateral capsular insertions, the anterior cruciate ligament (ACL), posterior
cruciate ligament (PCL) origins and insertions, PTI, biceps femoris inser-
tion, semimembranosus insertion, MPFL, and lateral patellofemoral liga-
ment (LPFL). Focal areas of abnormal signal adjacent to the superior and
inferior attachments of the posterior capsule and related calf muscle origins
were also considered as enthesitis.
MRI findings and data interpretation. Two observers, blinded to the diag-
nosis, interpreted the MRI findings in all patients and controls. Before inter-
pretation of MR images standards were established to look for all potential
sites of enthesitis and entheseal-related changes in both groups in the fol-
lowing anatomical sites — ACL, PCL, LCL, MCL, MPFL, LPFL, and PTI.
To avoid overreading or misinterpretation, potential entheseal sites
were evaluated by T2 fat saturation and STIR sequences for the assessment
of the tendon fibers, together with proton-density fat saturation for assess-
ment of perientheseal soft-tissue edema, and perientheseal BME with evi-
dent high signal intensity in case of enthesitis. To avoid misinterpretation
due to the “magic angle” effect, we relied on long TE pulse sequence for
the assessment of tendon or ligament fibers. In case of disagreements, the
findings were discussed according to the previous standards until agree-
ment was reached7.
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Statistical analysis. Quantitative variables were described using mean ± SD
and categorical data by frequency and percentage. The Pearson chi-square
test was used to test differences among categorical variables among the
groups of patients, and Student’s t test was used to compare quantitative
variables; in all tests, p value < 0.05 was considered to be statistically
 significant.
The study was approved by the local ethics committee of the Dr. Erfan
and Bagedo General Hospital and followed the principles of the
Declaration of Helsinki; all patients and controls gave written informed
consent before participation.
RESULTS 
A total of 48 consecutive outpatients [26 women (54.2%)
and 22 men (45.8%)] were included with psoriasis only and
with no clinical evidence of synovitis or enthesitis at clini-
cal examination. There were no refusals. Twenty healthy
subjects [12 women (60%) and 8 men (40%)] matched for
age and sex with no knee complaints served as controls. The
mean age of the patient group was 42.2 ± 7.5 years, and in
controls 40.65 ± 7.278 years. There were no significant dif-
ferences between the 2 groups regarding age and sex (p =
0.421, p = 0.659, respectively).
Demographic and disease characteristics, PASI, and lab-
oratory findings among the study group are described in
Table 1. MRI scans identified unilateral knee enthesitis in 22
(45.8%) and bilateral in 23 (47.9%) cases.
Detailed MRI findings among patients are described in
Table 2, including synovial thickness (Figure 1A-1D), vil-
lous projections (Figure 1D), knee effusion grading, STE,
BME (Figure 2A, 2B), perientheseal BME (Figure 3E), and
cartilaginous and bone erosions (Figure 1E-1H). Knee
enthesitis was absent in 3 cases (6.3%) and 90 lesions were
identified by MRI of the knees (Figures 3 and 4). No signif-
icant statistical differences between the right and left knees
were observed by any of these MRI findings (p > 0.05). In
the right knee, MCL enthesitis was identified in 4 (8.3%;
Figure 3C, 3D), LCL in 5 (10.4%; Figure 3E), ACL in 3
(6.3%; Figure 3H), PCL in 2 (4.2%), PTI in 21 (43.8%;
Figure 1B, 1D), MPFL in 5 (10.4%; Figure 1C), and LPFL
in 3 cases (6.3%); the total number of entheseal lesions in
the right knee was 43. In the left knee, MCL enthesitis was
observed in 9 (18.8%), LCL in 8 (16.7%), ACL in 2 (4.2%),
PCL in 3 (6.25%), biceps femoris insertion (intracapsular
and extrasynovial) in 1 (2.1%), PTI in 12 (25%; Figure 4),
MPFL in 9 (18.8%; Figure 3G), and LPFL in 3 cases (6.3%);
the total number of entheseal lesions in the left knee was 47.
No significant differences were observed between right and
left knees regarding the different entheseal lesions (p > 0.05).
In Table 3, detailed correlations are summarized
between the numbers of entheseal lesions detected in right
and left knees and enthesitis (unilateral vs bilateral) versus
demographic and disease characteristics and other MRI
findings.
No significant difference was observed between patients
and control groups regarding body mass index (p = 0.11),
while significant differences were observed between groups
regarding BME (p = 0.011) and cartilaginous erosions (p <
0.001; Table 3). In the controls, 2 subjects (10%) had BME
and another 5 (25%) showed cartilaginous erosions; none
showed evidence of enthesitis.
Significant correlations were observed between the
number of entheseal lesions of right and left knees versus
STE (present vs absent; r = 0.314, p = 0.030), and number
of STE lesions observed (r = 0.351, p = 0.014). Enthesitis
(unilateral vs bilateral) was positively correlated with STE
(r = 0.304, p = 0.036), cartilaginous erosions (present vs
absent; r = 0.304, p = 0.036), and villous projections (r =
0.347, p = 0.016; Table 4). Neither age nor disease duration
showed any correlation with the total number of entheseal
lesions (r = 0.042, p = 0.776 and r = −0.030, p = 0.841,
respectively; Table 4).
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Table 1. Demographic and clinical characteristics and laboratory findings
among the patients with psoriasis (n = 48). Data are mean ± SD or no. (%).
Characteristic
Age, yrs 42.2 ± 7.5
Male 22 (45.8)
Female 26 (54.2)
Disease duration, mo 82.9 ± 93.9
Age at onset, yrs 34.9 ± 9.3
PASI 1.99 ± 0.752
Nail changes 4 (8.3)
ESR, mm/h 8.6 ± 6.0
CRP, mg/dl 0.52 ± 0.41
PASI: Psoriasis Area and Severity Index; ESR: erythrocyte sedimentation
rate; CRP: C-reactive protein.
Table 2. MRI findings among the study patients. Data are mean ± SD or
no. (%).
MRI Sign Right Knee Left Knee
Synovial thickness, mm 1.45 ± 0.43 1.49 ± 0.38
Villous projections 8 (16.7) 6 (12.5)
Minimal knee effusion 47 (97.9) 47 (97.9)
Moderate knee effusion 1 (2.1) 1 (2.1)
Soft tissue edema 29 (60.4) 23 (47.9)
Bone marrow edema (BME) 9 (18.8) 11 (22.9)
Perientheseal BME 1 (2.1) 2 (4.2)
Cartilaginous erosions 23 (47.9) 19 (39.6)
Bone erosions 12 (25) 15 (31.3)
Medial collateral ligament 4 (8.3) 9 (18.8)
Lateral collateral ligament 5 (10.4) 8 (16.7)
Anterior cruciate ligament 3 (6.3) 2 (4.2)
Posterior cruciate ligament 2 (4.2) 3 (6.25)
Biceps femoris insertion 0 (0) 1 (2.1)
Patellar tendon insertion 21 (43.8) 12 (25)
Medial patellofemoral ligament 5 (10.4) 9 (18.8)
Lateral patellofemoral ligament 3 (6.3) 3 (6.3)
Extracapsular enthesitis 38 (79.2) 41 (85.4)
Intracapsular enthesitis 5 (10.4) 6 (12.5)
MRI: magnetic resonance imaging.
DISCUSSION 
Our case-control study was designed to investigate enthesi-
tis and subclinical synovitis of the knee joint in a cohort of
patients with psoriasis without clinical evidence of axial or
peripheral joint involvement.
Many factors appear to play a role in the development of
PsA in patients with psoriasis. It was found that lifting heavy
loads and infections that required antibiotics were associat-
ed with the occurrence of arthritis in patients with psoriasis.
There was an inverse association between smoking and
PsA8. In a followup study of 313 patients with psoriasis over
4 years by the same group, the annual incidence rate of PsA
was found to be 1.87 cases per 100 patients with psoriasis,
particularly among patients with moderate to severe
 psoriasis9.
Historically, “enthesitis” has been considered a disorder
of a focal attachment site; however, another concept consid-
ers that entheses together with adjacent tissues may form
mini-organs, dubbed “enthesis organs” by Benjamin and
colleagues10. On an anatomical basis, the normal “enthesis
organs” can be broadly classified as joint-related (here
called “articular”) or extraarticular, according to whether the
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Figure 1. A-D. Postcontrast T1 fat saturation magnetic resonance imaging (MRI) scan showing moderate knee effusion with synovial enhancement and vil-
lous projection in panel D. E-H. Sagittal T2 fat saturation MRI scan showing examples of bony and cartilaginous erosions close to the entheseal insertion of
quadriceps (E-G) and posterior cruciate ligament (H).
Figure 2. A. Sagittal T2 fat saturation magnetic resonance imaging (MRI) scan showing bone marrow edema (BME) of the posterior aspect of the medial
femoral condyle. B. Coronal T2 fat saturation MRI scan showing BME of femoral condyle. C. Sagittal T2 fat saturation MRI scan showing focal bone ero-
sions of the upper patellar pole. D. Sagittal T1 scan showing patellar cartilaginous erosions (arrow).
enthesis lies internally or externally to the capsule of a syn-
ovial joint11. At many locations there is a whole group of tis-
sue modifications in the immediate vicinity that collectively
constitute an enthesis organ. Each component plays a role in
the overall task of stress dissipation12.
Since the 1970s, it has been recognized that inflammato-
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Figure 3. A, B. Sagittal T2 fat saturation magnetic resonance imaging (MRI) showing enthesitis of quadriceps tendon (arrows). C, D. Coronal proton densi-
ty (PD) and T2 fat saturation MRI scans showing enthesitis of the medial collateral ligament (MCL; arrows). E, F. Axial PD fat saturation MRI scan show-
ing enthesitis of the lateral collateral ligaments with associated perientheseal bone marrow edema (arrows). G. Axial T2 fat saturation MRI showing com-
bined enthesitis of the medial patellofemoral ligament and MCL insertions (arrow). H. Sagittal PD fat saturation MRI showing enthesitis at the foot plate of
the anterior cruciate ligament (arrow).
Figure 4. A. Sagittal postcontrast T1 fat saturation magnetic resonance imaging (MRI) showing focal enhancement at the patellar insertion (thin arrow) and
quadriceps tendon attachment to the upper patellar pole (thick arrow). B. Sagittal T2 fat saturation MRI scan showing hyperintensity at the patellar tendon
(arrow). C. Sagittal STIR image showing hyperintensity and marrow edema at the upper patellar tendon attachment (arrow). D. Sagittal T2 fat saturation MRI
scan showing hyperintensities at the patellar tendon insertion (arrow).
ry lesions can develop without symptoms or signs that are
recognizable by the patient and the physician. Such patients
can be considered to have subclinical or “occult” PsA. The
concept of occult involvement in PsA could also be extend-
ed to patients already diagnosed with PsA in whom instru-
mental methods allow identification of more extensive dis-
ease, such as axial involvement in patients who have only
clinical peripheral arthritis/enthesitis, or polyarticular/enthe-
seal involvement in patients with clinical oligoarthritis/
enthesitis. Further research regarding the recognition and
progression of these occult forms could permit successful
early management of PsA13. MRI opened a new avenue of
research to explore hidden signs that can contribute to the
understanding of early disease changes in disorders of the
SpA group.
With respect to psoriasis, evidence of subclinical syn-
ovitis was previously supported and addressed a few times
in the literature using different techniques and in different
joints. In the earliest report, Namey and Rosenthall14
described markedly abnormal bone scintigraphy with sym-
metrically increased periarticular uptake about the imaged
joints in patients with psoriasis. Regarding hand joints,
Offidani, et al15 reported signs of occult synovitis by MRI
that were found in 68% of patients including joint or tendon
sheath effusions, bone erosions, and BME. In established
cases of PsA, Jevtic and coworkers16 using MRI described
inflamed tissue in the hand joints extending far beyond the
joint capsule, thickened collateral ligaments, and surround-
ing periarticular soft tissue, a pattern that is quite different
from that observed in patients with RA. In another report,
Tan, et al17 showed, using MRI, prominent inflammatory
changes in ligament, tendon, enthesis, and adjacent bone in
the distal interphalangeal (DIP) joints of patients with PsA,
and similar findings were observed in DIP joints among
patients with osteoarthritis (OA) but to a lesser extent.
Entheseal abnormalities have been documented by ultra-
sonography (US) in clinically asymptomatic patients with
psoriasis. These findings could relate to a subclinical enthe-
seal psoriatic inflammation18. Naredo, et al19 reported in
162 patients with plaque psoriasis without musculoskeletal
disease that patients with psoriasis had a significant preva-
lence of asymptomatic US synovitis and enthesopathy,
which may indicate a subclinical musculoskeletal involve-
ment. Additionally, 49 (36%) patients showed both synovi-
tis and enthesopathy. As in our study, Naredo, et al19
observed with US no significant differences between psori-
atic patients with and those without joint synovitis in terms
of demographic data and PASI scores.
In our study a total of 90 entheseal lesions were identi-
fied by MRI in both right and left knees and in only 3 cases
(6.3%) was enthesitis absent. This large number of entheseal
lesions may be explained by the sensitivity of MRI com-
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Table 3. Comparison of body mass index (BMI) and MRI findings among
patient and control groups.
Variable Patients, Controls, p
n = 48 n = 20
BMI, kg/cm2, mean ± SD† 34.24 ± 5.88 31.67 ± 6.34 0.11
Bone marrow edema, n (%) 20 (41.7) 2 (10) 0.011*
Cartilaginous erosions, n (%) 42 (87.5) 5 (25) < 0.001**
† Independent sample t test for equality of means; other data analyzed by
chi-square test. * Significant (p < 0.05); ** highly significant (p < 0.001).
MRI: magnetic resonance imaging.
Table 4. Correlations between number of entheseal lesions of both right and left knees and enthesitis (unilater-
al vs bilateral), versus demographic and clinical characteristics and MRI findings.
No. Entheseal Lesions Enthesitis Unilateral vs Bilateral
Variable r p r p
Age, yrs 0.042 0.776 –0.051 0.730
Disease duration, mo –0.030 0.841 –0.039 0.794
Age at onset, yrs 0.045 0.760 0.014 0.927
Nail changes, present vs absent –0.057 0.699 0.041 0.780
Skin score, PASI 0.076 0.609 0.079 0.594
STE, present vs absent 0.314 0.030* 0.304 0.036*
BME, present vs absent 0.235 0.107 0.053 0.720
Perientheseal BME, present vs absent 0.224 0.125 0.029 0.847
Cartilaginous erosions, present vs absent 0.145 0.325 0.304 0.036*
Bone erosions, present vs absent 0.043 0.773 0.056 0.708
Villous projections, present vs absent 0.085 0.566 0.338 0.019*
STE, no. lesions 0.351 0.014* 0.313 0.031*
BME, no. lesions –0.082 0.581 0.053 0.720
Perientheseal BME, no. lesions 0.146 0.323 –0.027 0.855
Cartilagenous erosions, no. lesions 0.131 0.375 0.229 0.117
Bone erosions, no. lesions 0.051 0.730 0.138 0.351
Villous projections, no. lesions 0.099 0.502 0.347 0.016*
PASI: Psoriasis Area and Severity Index; STE: soft-tissue edema; BME: bone marrow edema. * p < 0.05.
pared to US from the technical point of view. Further, an
important sign on MRI is BME, which cannot be detected
except with the use of MRI. In our study 20 cases showed
evidence of BME signs in both knees.
We have confirmed in a large series of patients with pso-
riasis the findings of knee enthesitis in almost all cases and
other signs of synovitis as well. Importantly, we ensured the
presence of MRI enthesitis at different anatomical sites by
combined interpretation of STIR sequences as a sensitive
measure for detection of perientheseal BME, while T2 fat
saturation was better for anatomical delineation of the
entheseal organ. In our study, no controls showed evidence
of enthesitis on MRI and only 2 subjects (10%) had BME,
and another 5 (25%) showed cartilaginous erosions, which
can be explained as early osteoarthritic age-related changes.
However, the later findings were significantly higher in the
patient group compared to the controls (p = 0.01, p < 0.001,
respectively), and this again may be indicative of a subclin-
ical form of synovitis among patients with psoriasis. The
other important finding is the presence of villous projec-
tions, which is in our opinion an early phase for pannus for-
mation, reflecting the early inflammatory process. In recent
work Gibson and coworkers20 observed no increase in the
prevalence of hand enthesophytes among patients with knee
BME on MRI scans. This in turn provides evidence against
a systemic enthesopathic disorder in association with knee
OA.
Prospective studies in patients with early SpA will be
necessary to determine whether enthesitis and synovitis
coexist at all stages of synovitis, or if in fact synovitis even-
tually becomes autonomous21. Moreover, in PsA, subclini-
cal enthesopathy including osteitis is common in subjects
with psoriasis but without arthritis22.
In our study it was notable that the total number of
entheseal lesions in right and left knees was positively cor-
related with STE (present vs absent; p = 0.03) and with
number of STE of both right and left knees (p = 0.014). On
the other hand, enthesitis (unilateral vs bilateral) was posi-
tively correlated with STE (present vs absent; p = 0.036),
cartilaginous erosions (present vs absent; p = 0.036), num-
ber of STE lesions of both knees (p = 0.031), and villous
projections (whether taken as present vs absent or number of
lesions of both knees; p = 0.019,  p = 0.016, respectively).
Such clear correlations indicate a close link of enthesitis
with other important MRI signs previously mentioned,
which definitely indicate continuing inflammation that
remains subclinical and cannot be observed except with the
use of a sensitive technique such as MRI. None of our
patients received methotrexate (MTX) therapy to control
their skin disease at the time of the study. Low-dose MTX is
an effective treatment for psoriasis and PsA23.
A drawback in our study is that we did not have 2
observers presenting 2 separate scores, which would have
made it possible to estimate interobserver reliability. We
chose the agreement method7, which is less robust. We fol-
lowed a “gold standard” interpretation of all MRI findings
and all findings were individually discussed until agreement
was reached.
In the knee joints of patients with psoriasis, MRI showed
evidence of subclinical synovitis and enthesitis that were
more frequent with extracapsular enthesitis compared to
intracapsular involvement. Enthesitis was positively and
significantly correlated with other important MRI signs,
such as villous projections, STE, and cartilaginous erosions,
that were indicative of continuing subclinical synovitis.
These findings indicate that enthesitis may be an early sign
(perhaps the earliest) of subclinical psoriatic arthritis.
REFERENCES 
1. Ragab Y, Emad Y, Hanan D, el Nashwa S, Rasker JJ. Enthesitis in
seronegative spondyloarthropathies with special attention to the
knee joint by MRI: A step forward toward understanding disease
pathogenesis. Clin Rheumatol 2011;30:313-22.
2. McGonagle D. Imaging the joint and enthesis: Insights into
 pathogenesis of psoriatic arthritis. Ann Rheum Dis 2005;64 Suppl
II:58-60.
3. McGonagle DS, Gibbon W, O’Connor P, Green M, Pease C, Emery
P. Characteristic magnetic resonance imaging entheseal changes of
knee synovitis in spondyloarthropathy. Arthritis Rheum
1998;41:694-700.
4. Emad Y, Ragab Y, Bassyouni I, Moawayh O, Fawzy M, Saad A, et
al. Enthesitis and related changes in the knees in seronegative
spondyloarthropathies and skin psoriasis: Magnetic resonance
imaging case-control study. J Rheumatol 2010;37:1709-17.
5. Emad Y, Ragab Y, Shaarawy A, Abou-Zeid A, Saad A, Fawzy M, et
al. Can magnetic resonance imaging differentiate undifferentiated
arthritis based on knee imaging? J Rheumatol 2009;36:1963-70.
6. Van de Kerkhof PC, Schalkwijk J. Psoriasis. In: Bolognia JL,
Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. London:
Mosby; 2008:115-48.
7. Ostergaard M, Conaghan PG, O’Connor P, Szkudlarek M, Klarlund
M, Emery P, et al. Reducing invasiveness, duration and cost of
magnetic resonance imaging in rheumatoid arthritis by omitting
intravenous contrast injection — Does it change the assessment of
inflammatory and destructive joint changes by the OMERACT
RAMRIS? J Rheumatol 2009;36:1806-10.
8. Eder L, Law T, Chandran V, Shanmugarajah, Shen H, Rosen CF, et
al. Association between environmental factors and onset of
 psoriatic arthritis in patients with psoriasis. Arthritis Care Res
2011;63:1091-7.
9. Eder L, Law T, Chandran V, Shen H, Cook RJ, Shanmugarajah S, et
al. Incidence of arthritis in a prospective cohort of psoriasis
patients. Arthritis Care Res 2011;63:619-22.
10. Benjamin M, Moriggl B, Brenner E, Emery P, McGonagle D,
Redman S. The “enthesis organ” concept: Why enthesopathies may
not present as focal insertional disorders. Arthritis Rheum
2004;50:3306-13.
11. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann
Rheum Dis 1971;30:213-23.
12. McGonagle D, Benjamin M. Entheses, enthesitis and enthesopathy.
Reports on the Rheumatic Diseases. Topical Reviews 2009; Series
6, No. 4. [Internet. Accessed June 22, 2012.] Available from:
http://www.arthritisresearchuk.org/health-professionals-and-students/
reports/reports-archives/~/media/Files/Education/Topical-Reviews/
TR04-Autumn-2009.ashx
13. Palazzi C, Lubrano E, D’Angelo S, Olivieri I. Beyond early
1985Emad, et al: Synovitis by MRI in psoriasis 
Personal non-commercial use only. The Journal of Rheumatology Copyright © 2012. All rights reserved.
 diagnosis: Occult psoriatic arthritis. J Rheumatol 2010;37:1556-8.
14. Namey T, Rosenthall L. Periarticular uptake of 99m technetium
diphosphonate in psoriatics: Correlation with cutaneous activity.
Arthritis Rheum 1976;19:607-12.
15. Offidani A, Cellini A, Valeri G, Giovagnoni A. Subclinical joint
involvement in psoriasis: Magnetic resonance imaging and X-ray
findings. Acta Derm Venereol Stockh 1998;78:463-5.
16. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O.
Distinctive radiological features of small hand joints in rheumatoid
arthritis and seronegative spondyloarthritis demonstrated by
 contrast-enhanced (Gd-DTPA) magnetic resonance imaging.
Skeletal Radiol 1995;24:351-5.
17. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D. A  
high-resolution magnetic resonance imaging study of distal
 interphalangeal joint arthropathy in psoriatic arthritis and
osteoarthritis: Are they the same? Arthritis Rheum 2006;
54:1328-33.
18. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD.
Ultrasonography of entheseal insertions in the lower limb in
spondyloarthropathy. Ann Rheum Dis 2002;61:905-10.
19. Naredo E, Batlle-Gualda E, García-Vivar ML, García-Aparicio AM,
Fernández-Sueiro JL, Fernández-Prada M, et al; Ultrasound Group
of the Spanish Society of Rheumatology. Power Doppler
 ultrasonography assessment of entheses in spondyloarthropathies:
Response to therapy of entheseal abnormalities. J Rheumatol
2010;37:2110-7.
20. Gibson N, Guermazi A, Clancy M, Niu J, Grayson P, Aliabadi P, et
al. Relation of hand enthesophytes with knee enthesopathy: Is
osteoarthritis related to a systemic enthesopathy? J Rheumatol
2012;39:359-64.
21. McGonagle D, Stockwin L, Isaacs J, Emery P. An enthesitis based
model for the pathogenesis of spondyloarthropathy: Additive
effects of microbial adjuvant and biomechanical factors at disease
sites. J Rheumatol 2001;28:2155–9.
22. McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ. The
early phase of psoriatic arthritis. Ann Rheum Dis 2011;70 Suppl
1:i71-6.
23. Kuhn A, Ruland V, Patsinakidis N, Luger TA. Use of methotrexate
in patients with psoriasis. Clin Exp Rheumatol 2010;28 Suppl
61:S138-44.
1986 The Journal of Rheumatology 2012; 39:10; doi:10.3899/jrheum.120301
Personal non-commercial use only. The Journal of Rheumatology Copyright © 2012. All rights reserved.
